A Cross-Sectional Study of Psychiatric Manifestations Following Oseltamivir Administration for Suspected Patients with H۱N۱ Swine Influenza Infection
Publish place: Journal of Cardio-Thoracic Medicine، Vol: 10، Issue: 1
Publish Year: 1401
نوع سند: مقاله ژورنالی
زبان: English
View: 210
This Paper With 6 Page And PDF Format Ready To Download
- Certificate
- من نویسنده این مقاله هستم
این Paper در بخشهای موضوعی زیر دسته بندی شده است:
استخراج به نرم افزارهای پژوهشی:
شناسه ملی سند علمی:
JR_JCTM-10-1_002
تاریخ نمایه سازی: 16 فروردین 1401
Abstract:
Introduction: Oseltamivir is an antiviral drug used to treat H۱N۱ influenza. FDA added a warning to the label of oseltamivir drawing attention to the risk of developing neuropsychiatric adverse events. There are some case reports reported psychiatric symptoms on oseltamivir intake. However, data is scarce on the emergence of psychiatric symptoms following oseltamivir administration.Materials and Methods: Sixty patients, who received oseltamivir for prophylaxis or treatment for H۱N۱ swine influenza in the preceding six months, were enrolled in this study. The mini neuropsychiatric screener for DSM۴ and a semi-structured proforma was applied that included socio-demographic information of patients, past psychiatric history, medical comorbidities, use of concomitant medication, dose and duration of use of oseltamivir. T-test and chi-square test were used to compare parametric data and categorical data respectively. P-value ≤ ۰.۰۵ was used for statistical significance.Results: Of ۶۰ patients, ۲۲(۳۶.۶۷%) patients had developed psychiatric symptoms after receiving oseltamivir. ۱۱(۵۰%) patients had sleep issues, and there were ۶(۲۷%) patients with delirium, ۳(۹%) with depression and ۳(۹%) with anxiety and ۱(۵%) with psychosis. Among ۲۲ patients, ۴ subjects had past history of psychiatric illness (p-value = ۱.۰۰) and ۱۵ had past medical illness (p-value = ۰.۰۰۳). Patients who developed psychiatric manifestations were significantly older (p-value: ۰.۰۵) and had lower years of education (p-value: ۰.۰۱).Conclusions: ۳۶.۶۷% of patients developed psychiatric side effects following oseltamivir use. Predominant symptoms included sleep issues and delirium. Those who developed psychiatric symptoms had a significant background history of medical illness. Therefore, it is recommended that those who receive oseltamivir regularly be screened for psychiatric symptoms.
Keywords:
Authors
Basavaraju Jayadeva
Department of Respiratory Medicine, Bangalore Medical College & Research institute, Bangalore, India.
Shankar Kumar
Department of Psychiatry, Bangalore Medical College and Research Institute, Bangalore, India.
Sushmitha Kota
Department of Psychiatry, Bangalore Medical College and Research Institute, Bangalore, India.
Aashik Shekar
Department of Medicine, Bangalore Medical College & Research Institute, Bangalore, India.
مراجع و منابع این Paper:
لیست زیر مراجع و منابع استفاده شده در این Paper را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود Paper لینک شده اند :